JWS
SCMP

Juncture Wealth Strategies’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Juncture Wealth Strategies’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-35,426
Closed -$387K – 79
2016
Q1 		$387K Buy
35,426
+145
+0.4% +$1.83K 0.29% 66
2015
Q4 		$610K Buy
+35,281
New +$633K 0.46% 55
2015
Q3 		– Sell
-13,351
Closed -$219K – 88
2015
Q2 		$219K Buy
+13,351
New +$231K 0.18% 70

Other funds holding SCMP

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Juncture Wealth Strategies's SCMP Position: Q2 2016 in Review

Juncture Wealth Strategies sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2016, closing a stake of 35,426 shares — an estimated $387K sold.

Juncture Wealth Strategies first reported a position in SCMP in Q2 2015 and held it in 3 quarters. The position peaked at $610K in Q4 2015. 136 funds tracked by Wall St. Rank hold SCMP as of Q2 2016.

  • Juncture Wealth Strategies reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Juncture Wealth Strategies sold 35,426 Sucampo Pharmaceuticals, Inc. shares in Q2 2016, an estimated $387K.
  • Juncture Wealth Strategies first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 3 quarters.
  • Juncture Wealth Strategies's Sucampo Pharmaceuticals, Inc. position peaked at $610K in Q4 2015.
  • 136 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2016.

Based on Juncture Wealth Strategies's 13F filing for Q2 2016, filed 14 Jul 2016.